SERVICES - RESEARCH PHASE
We undertake “bench-to-bedside approach” to overcome complexity, lengthiness and huge financial burden of drug discovery and research.
RESEARCH PHASE
Pipeline Assessment
​
KOL Research
​
Indication/Asset Prioritization
​
Opportunity Assessment
​
Whitespace Analysis
Pipeline Assessment
Identification of all possible therapeutic targets in a given therapy area with their mechanism-of-action (MOA), route-of-administration (ROA) and a fresh look at their patent landscape.
KOL Research
Identification of key opinion leaders that can contribute towards early drug development process as well as share key marketing feedback - they contribute significantly in validating drug targets, understanding marketing trends and carrying out advocacy support.
Indication/Asset Prioritization
Indication/asset prioritization services are based on a combination of primary and secondary research. Many key pointers, that are scouted using secondary research, are subsequently vetted and validated by primary research, wherein we interact with KOLs across the 5Ps of healthcare.
Opportunity Assessment
In-depth analysis to understand the micro and macro environment of the market and assess the feasibility of launching or not launching a product or service and devising the strategy for execution.
Whitespace Analysis
Identification of healthcare technology areas lacking in significant research activity, thereby presenting an opportunity for the client to be the first-mover in those areas.
DEVELOPMENT PHASE
Clinical Trial Mapping
​
Product Milestones
​
State-of-the-Art Study
​
Regulatory Writing
Clinical Trial Mapping
The depiction of heat maps indicating the status of the clinical trials with respect to completion timelines/location/primary and secondary end-points, and mapping them to see if there have been changes in any of these criteria.
Product Milestones
A comprehensive report reflecting product development milestones (regulatory, market access and pricing, patent filing, financial milestones) and event milestones.
State-of-the-Art Study
A thorough analysis to understand the state of innovation around a particular healthcare technology area, thereby deriving assistance in formulating business strategies.
Regulatory Writing
Complete regulatory support for the ever-changing regulatory needs in a constantly evolving and dynamic pharmaceutical and medical devices landscape.
MARKETING /PRODUCT LAUNCH SERVICES
Market Dynamics Study
Market Dynamics Study
Devise an actionable strategy for our clients to help them understand their markets/their customers and take tactical and strategic decisions.
​
Some of the exemplary market dynamics studies encompass Market Entry, Market Sizing, Go-to-Market Strategy, etc.
EXCLUSIVE SERVICES
Competitive Intelligence
​
Product Intelligence
​
Asset Mapping & Profiling
​
Syndicated Reports
Competitive Intelligence
A thorough analysis to provide an extensive research support to client’s area of interests and identifying his research needs so as to help him/her gain a significant competitive advantage.
Product Intelligence
Our product intelligence services encompass all available information related to a product from market-related, regulatory-related, launch-related to IP-related.
Asset Mapping & Profiling
Our detailed asset mapping and profiling services includes synthesizing important information from asset pipeline reports, and then carrying out detailed profiling w.r.t. clinical trials, their target population, ROA, any partnerships and commercial licenses, and regulatory updates.
Syndicated Reports
An extensive document to provide a bird’s eye view of current and upcoming therapeutic targets/biomedical devices/analytical techniques in the form of syndicated reports, that are handy, as well as effective in terms of cost and time.
THE INTEllIGIENCE EDGE
Expertise across the entire healthcare and pharmaceutical landscape
Intelligent combination of market research and IP/technology research
Flexible business models to meet different client needs
One stop shop for a gamut of services
